Tessera Therapeutics

About Tessera Therapeutics

Tessera Therapeutics focuses on genetic medicine, utilizing a technology called Gene Writing to make precise changes to the human genome. This technology allows for permanent alterations to genetic material in any cell, which can potentially cure diseases at their source. Tessera's Gene Writing platform can perform both small and large genetic modifications, making it applicable to a wide range of genetic disorders. The company primarily serves research institutions, pharmaceutical companies, and healthcare providers looking to develop new treatments for genetic diseases. Unlike its competitors, Tessera Therapeutics emphasizes the versatility of its technology and its ability to address previously untreatable conditions. The company's goal is to advance the development of its Gene Writing platform to ultimately cure diseases by rewriting the genetic code.